Osteoarthritis is the most common degenerative joint disorder, afflicting mainly the weight-bearing joints, such as hips and knees, is the leading cause of physical disability and has been predicted to affect 67 million people in the United States by 2030 (ref. 1). Despite identified risk factors (for example, mechanical, metabolic or genetic factors) the exact pathogenesis of osteoarthritis remains unclear 2 . Currently there is no effective disease-modifying treatment for osteoarthritis, necessitating joint replacement as a therapeutic option 3,4 . Articular cartilage degeneration is the primary concern in osteoarthritis, which has recently been attributed to hypoxia-inducible factor-2α (HIF-2α) 5,6 and complement component 5 (C5) 7 , in addition to the well-established factors ADAM metallopeptidase with thrombospondin type 1 motif, 5 (ADAMTS5) 8 and matrix metalloproteinase 13 (MMP13) 9 . The homeostasis and integrity of articular cartilage rely on its biochemical and biomechanical interplay with subchondral bone and other joint tissues 10 . Subchondral bone provides the mechanical support for overlying articular cartilage during the movement of load-bearing joints and undergoes constant adaptation in response to changes in the mechanical environment through modeling or remodeling 11 . As a result of instability of mechanical loading on such joints, for example, as occurs with ligament injury, excessive body weight or weakening muscles during aging, the subchondral bone and calcified cartilage zone undergo changes 12 . For instance, rupture of the ACL increases the risk of knee osteoarthritis 13 , and approximately 20-35% of individuals with osteoarthritis are estimated to have had an incidental ACL tear 14, 15 . Clinically, osteophyte formation, subchondral bone sclerosis, disruption of the tidemark accompanied by angiogenesis at the osteochondral junction and articular cartilage degeneration are characteristics of osteoarthritis 16 . Further, bone marrow lesions are closely associated with pain and have been implicated to predict the severity of cartilage damage in osteoarthritis 17 . In healthy articular cartilage, matrix turnover remains at relatively low rates, and chondrocytes resist proliferation and terminal differentiation 18 . During the progression of osteoarthritis, type X collagen, alkaline phosphatase, runt-related transcription factor 2 (RUNX2) and MMP13 are expressed in articular chondrocytes with low amounts of proteoglycans and expanded calcified cartilage zones in articular cartilage 2,19 . However, the exact mechanism underlying the potential contributions of defective subchondral bone to articular cartilage degeneration during osteoarthritis progression is largely unknown.
maintenance of articular cartilage metabolic homeostasis and structural integrity 20 . It also stimulates chondrocyte proliferation, and knockout of TGF-β1 or interruption of TGF-β signaling in articular cartilage results in loss of proteoglycans and cartilage degeneration in mice 21, 22 . The predominance of phosphorylated Smad1 and Smad5 (pSmad1/5) due to the elevated expression ratio of ALK1 to ALK5 in articular cartilage might contribute to the pathogenesis of osteoarthritis [23] [24] [25] . Several groups have demonstrated that ablation of endogenous TGF-β1 activity suppresses osteophyte formation in vivo but aggravates articular cartilage degeneration in osteoarthritis mice models 26, 27 . We have previously shown that TGF-β1 is activated during osteoclastic bone resorption and induces the migration of bone marrow MSCs to resorption pits for new trabecular bone formation in the long bone, serving as a coupling factor 28 . In this study we investigated the role of TGF-β1 in subchondral bone pathology and articular cartilage degeneration during the progression of osteoarthritis. We found that inhibition of TGF-β1 activity in subchondral bone attenuated its pathological changes and led to less degeneration of articular cartilage relative to untreated groups in different osteoarthritis rodent models.
RESULTS

Elevated TGF-b levels in subchondral bone after ACLT
To examine subchondral bone changes at the onset of osteoarthritis, we transected the ACL in 2-month-old mice to generate a destabilized osteoarthritis animal model and analyzed the effects over time. The tibial subchondral bone volume in ACLT mice changed substantially relative to sham-operated control mice after surgery as determined by three-dimensional microcomputed tomography (µCT) analysis (Fig. 1a) . The total subchondral bone tissue volume was more than 20% higher in the ACLT mice compared to sham-operated controls by 2 months after surgery (Fig. 1b) . The thickness of the subchondral bone plate (SBP) fluctuated significantly in the ACLT mice from 14 to 60 d after surgery, with abnormal morphology present by 60 d (Fig. 1c) . Moreover, the disruption of the connectivity and microarchitecture of trabecular bone was indicated by a significantly higher trabecular pattern factor (Tb.Pf) 29 in the ACLT mice compared to sham-operated controls (Fig. 1d) , indicating uncoupled bone remodeling. We also observed the pathological changes in subchondral bone in the knee joints of humans with osteoarthritis ( Supplementary Fig. 1) .
We observed proteoglycan loss in cartilage in the ACLT mice at 30 d after surgery, which was further aggravated at 60 d ( Fig. 1a) . Notably, we detected proteoglycan loss at the deep zone of articular cartilage in the ACLT mice. H&E staining showed that the thickness of the calcified cartilage zone in these mice was greater than that in age-matched sham-operated mice, with the tidemark moving closer to the articular surface. (Fig. 1a) . Osteoarthritis Research Society International (OARSI) scores 30 revealed degeneration of articular cartilage that started at 14 d after ACLT and progressed gradually (Fig. 1e) . Indeed, in a computerized simulation model for human knee joints, expansion and increased stiffness of subchondral bone changed the distribution of articular cartilage stress (Supplementary Fig. 2) .
TRAP staining showed that the number of osteoclasts increased in subchondral bone as early as 7 d after ACLT, and the continued osteoclastic bone resorption generated large bone marrow cavities by 30 d (Fig. 1a,f) . Immunostaining demonstrated that after surgery, the number of cells positive for phosphorylated Smad2/3 (pSmad2/3 + ) was higher at 7 d as compared to baseline at day 0, remained at high concentrations until 30 d and then returned to approximate baseline numbers by 60 d (Fig. 1f) . These results suggest that altered mechanical loading induced subchondral bone resorption with elevated active TGF-β concentrations in this region. 
Expression of active TGF-b1 in bone induces osteoarthritis
In Camurati-Engelmann disease (CED), TGF-β1 is activated after secretion as a result of a point activating mutation in the Tgfb1 gene 28, 31 , and people with CED are prone to developing osteoarthritis 20, 32 . To examine whether high concentrations of active TGF-β1 in subchondral bone initiate osteoarthritis, we used a CED activation mutation mouse model in which TGF-β1 is activated after secretion in the subchondral bone marrow by osteoblastic cells. Threedimensional µCT images of cross-sectional, coronal and sagittal views of tibial subchondral bone showed an uneven distribution of bone mass in CED mice relative to wild-type (WT) littermates, indicating disrupted bone formation ( Fig. 2a) . Similarly to in the ACLT mouse model, the tibial subchondral bone tissue volume and Tb.Pf were greater, whereas the thickness of the SBP was less, in CED mice relative to their WT littermates. Notably, we detected markedly lower proteoglycan expression at the calcified cartilage zone adjacent to the SBP in the CED mice ( Fig. 2b) . Compared to WT littermates, the thickness of the calcified cartilage layer was greater in the CED mice, whereas the thickness of the hyaline cartilage layer was less and had apparent hypocellularity ( Fig. 2b) . OARSI scores revealed significant degeneration of articular cartilage in CED mice relative to age-matched WT littermates ( Fig. 2c) . We also measured angiogenesis in these mice using microfil contrast-enhanced angiography, as elevated angiogenesis is a pathological manifestation of osteoarthritis 33 . The volume fraction and number of blood vessels in subchondral bone were significantly higher in CED mice relative to their WT littermates ( Fig. 2d) . Consistently, the number of CD31 + endothelial progenitor cells was also higher ( Fig. 2e) . Immunostaining for nestin, which is expressed primarily in adult bone marrow MSCs 34, 35 , revealed a significantly higher number of nestin-positive cells in the subchondral bone marrow of CED mice compared to WT controls ( Fig. 2f) . Once committed to the osteoblast lineage, MSCs express osterix, a marker of osteoprogenitors. The number of osterix-positive osteoprogenitors was also significantly higher in the subchondral bone marrow of CED mice compared to WT controls ( Fig. 2f) , indicating that nestin-positive MSCs undergo osteoblastic differentiation to contribute to de novo bone formation. We also observed clustering of osterix-positive osteoprogenitors in the bone marrow cavity in the subchondral bone of ACLT mice (Supplementary Fig. 3 ).
In addition, we measured active TGF-β1 in subchondral bone of human knee joints at different stages of osteoarthritis. ELISA analysis showed that the concentrations of active TGF-β1 in the subchondral bone of knee joints of people with osteoarthritis were significantly higher than in those of healthy controls ( Fig. 2g) . Collectively, development of the knee joint osteoarthritis phenotype in CED mice was similar to that observed in the ACLT mouse model, revealing that high concentrations of active TGF-β1-induced abnormal subchondral bone formation may contribute to the degeneration of articular cartilage.
Inhibition of TGF-b signaling attenuates cartilage damage
We next examined the effects of inhibition of TGF-β activity on the joints of ACLT mice. Injection of a TβRI inhibitor (SB-505124) has been shown to rescue uncoupled bone formation induced by high concentrations of active TGF-β1 (ref. 28 ). We screened different npg doses of the TβRI inhibitor in ACLT mice to identify the optimal dose ( Supplementary Fig. 4 ). Low concentrations of the TβRI inhibitor (0.1 or 0.5 mg per kg body weight) had minimal effects on subchondral bone, whereas higher concentrations, beginning at 1 mg per kg body weight, improved subchondral bone structure ( Fig. 3a) . Conversely, proteoglycan loss in articular cartilage was induced at higher concentrations (2.5 or 5 mg per kg body weight) ( Supplementary Fig. 4a ). Of note, we observed proteoglycan loss induced by higher doses of the inhibitor primarily in the superficial to middle zones of articular cartilage ( Supplementary Fig. 4a ). As treatment with the TβRI inhibitor prevented uncoupled bone resorption and formation ( Supplementary Fig. 5 ), we found improvement of trabeculae connectivity and microarchitecture with 1 mg per kg body weight of the TβRI inhibitor, as demonstrated by normalization of subchondral bone tissue volume ( Fig. 3b) , maintenance of the thickness of the SBP (Fig. 3c ) and a lower volume in Tb.Pf relative to vehicle-treated ACLT mice ( Fig. 3d) . Notably, proteoglycan loss and calcification of articular cartilage were attenuated in ACLT mice 2 months after surgery, a time point that is often used for analysis in destabilized osteoarthritis mice models 36 (Fig. 3e) . We quantified the protective effect of the TβRI inhibitor on articular cartilage in TβRI inhibitor-treated compared to vehicle-treated ACLT mice using the OARSI system (Fig. 3f) . The inhibitor, however, had no significant effects on the elevated concentrations of MMP13 or type X collagen in chondrocytes as compared to vehicle treatment ( Fig. 3g,h) .
We repeated the TβRI inhibitor treatment experiments in 9-monthold mice with ACLT or sham operation. Similarly, subchondral bone structure was improved and articular cartilage degeneration was attenuated in ACLT mice treated with 1 mg per kg body weight of the TβRI inhibitor ( Supplementary Fig. 6 ). Moreover, gait analysis with the CatWalk system revealed significant disparity between the percentages of maximum contact time of the two hind limbs at 2 months after surgery, which was rescued in the inhibitor-treated ACLT group (Fig. 3i) . Taken together, these results indicate that TGF-β has distinct roles in subchondral bone and articular cartilage, and inhibition of TGF-β activity in subchondral bone may prevent the degeneration of articular cartilage during osteoarthritis development.
Increase of MSCs leads to formation of osteoid islets
To examine the cellular mechanism of TβRI inhibitor-attenuated progression of osteoarthritis, we analyzed the effect of the TβRI inhibitor on MSCs in subchondral bone. We found by immunostaining that the number of nestin-positive MSCs in the subchondral bone marrow was substantially higher by 30 d after surgery in ACLT mice compared to sham-operated controls (Fig. 4a) . This effect was prevented by the TβRI inhibitor ( Fig. 4a) . Similarly, osterix-positive osteoprogenitors were located largely on the bone surface in sham-operated controls (Fig. 4a) , and the significantly higher number of osteoprogenitor clusters detected in the bone marrow of vehicle-treated ACLT mice was attenuated with TβRI inhibitor treatment ( Fig. 4a) . We confirmed these results using a flow cytometry analysis of nestin-positive MSCs and osterix-positive osteoprogenitors from subchondral bone ( Fig. 4) . We found osteocalcin-positive osteoblasts and osteoids as islets in the subchondral bone marrow of ACLT mice. As compared to vehicletreated ACLT mice, injection of the TβRI inhibitor resulted in less abnormal localization, as the osteocalcin-positive osteoblasts and osteoid were located largely on the bone surface, which was similar to their location in the sham-operated controls (Fig. 4b) . Formation of osteoid islets was lower in the TβRI inhibitor-treated group as compared to the vehicle-treated group in fluorescent double-labeling experiments (Fig. 4d) .
Phosphorylation of Smad1 can be activated by TGF-β1 in endothelial progenitor cells 37 . Thus, we examined whether TGF-β1 activates phosphorylation of Smad1 in MSCs. We found that TGF-β1 stimulated npg the phosphorylation of both Smad2/3 and Smad1/5/8 at low concentrations, but the highest amount of pSmad1/5/8 was achieved with a higher dose of TGF-β1 (5 ng ml −1 ) (Fig. 4e) . Immunostaining of the subchondral bone showed that the number of pSmad1 + cells remained relatively stable in ACLT mice treated with the TβRI inhibitor relative to sham-operated controls (Fig. 4f) . In contrast, the number of pSmad2/3 + cells was higher in ACLT mice, and this effect was prevented by TβRI inhibitor treatment ( Fig. 4f) , suggesting that phosphorylation of Smad2/3 is the primary downstream signal of TGF-β in subchondral bone MSCs. Consistently, the expression of ALK1 remained unchanged in ACLT mice treated with vehicle or inhibitor relative to sham-operated control mice, whereas the expression of ALK5 was significantly higher in ACLT mice relative to shamoperated control mice, and this effect was inhibited by injection of npg the TβRI inhibitor (Fig. 4f) . The number of CD31 + endothelial progenitors was significantly higher in the subchondral bone of ACLT mice relative to sham-operated controls, and this effect was reduced by injection of the TβRI inhibitor ( Fig. 4g) .
Microfil contrast-enhanced angiography of subchondral bone confirmed that the inhibitor-treated group had less angiogenesis than the vehicle-treated group (Fig. 4h) . The contrast signal was substantially stronger in vehicle-treated mice at 1 month after ACLT as compared to vehicle-treated sham-operated mice in magnetic resonance imaging (MRI) perfusion analysis, and we did not detect this stronger signal in the inhibitor-treated group, indicating less new vessel formation ( Fig. 4i and Supplementary Fig. 7) . The bone marrow lesion in the tibial subchondral bone detected by micro-MRI was also smaller in the ACLT inhibitor-treated mice compared to in the ACLT vehicletreated mice (Fig. 4j) , suggesting the association of bone marrow lesions with osteoid islets. These results indicate that high concentrations of active TGF-β increased the number of nestin-positive MSCs, leading to subchondral bone marrow osteoid islets and angiogenesis, which are pathological changes of this region after ACLT.
Antibody and genetic targeting of TGF-b in osteroarthritis
To validate the role of TGF-β in subchondral bone at the onset of osteoarthritis, we implanted an antibody to TGF-β (1D11) 38, 39 in alginate beads 40, 41 directly in the tibial subchondral bone of the joints of ACLT rats. We then harvested the knee joints at 3 months after surgery. Similarly to systemic use of the TβRI inhibitor, the microarchitecture of the bone was improved with local application of the antibody as compared to treatment with vehicle in ACLT rats ( Fig. 5a-d) .
The number of osterix-positive progenitor clusters in the bone marrow cavities of the joints of ACLT rats was significantly less in the antibody-treated rats compared to in the vehicle-treated rats (Fig. 5e) .
Notably, degeneration of articular cartilage was attenuated by administration of the antibody in subchondral bone, as reflected in OARSI scores ( Fig. 5f,g) . Moreover, the percentages of MMP13 + and type X collagen-positive chondrocytes were lower in the antibodytreated than the vehicle-treated ACLT rats, indicating protection from degeneration of articular cartilage (Fig. 5h) . In contrast, the elevated MMP13 and type X collagen expression was not abolished by systemic injection of TβRI inhibitor (Fig. 3g,h) , as TGF-β is essential for the homeostasis of articular cartilage. Therefore, specific administration of the antibody to TGF-β in subchondral bone suppressed aberrant bone formation but did not inhibit TGF-β signaling in articular cartilage. The protective effect on articular cartilage in our rat osteoarthritis model was primarily through an improvement of subchondral bone by site-specific administration of the antibody to TGF-β. These results further validate that the role of TGF-β in the subchondral bone is distinct from its role in articular cartilage; high concentrations of active TGF-β1 in the subchondral bone induced abnormal bone formation, leading to the development of osteoarthritis.
TGF-β binds to a complex of TβRII and TβRI to induce phosphorylation of downstream Smad2/3. Deletion of Tgfbr2 ensures blocking of the TGF-β signaling cascade. We induced knockout of Tgfbr2 in nestin-positive MSCs of ACLT mice to confirm the crucial role of TGF-β signaling in MSCs at the onset of osteoarthritis. We npg to TGF-β, whereas the TGF-β signaling pathway in other cell types, including chondrocytes, remained intact (Supplementary Fig. 8 ).
Similarly to with TβRI inhibitor treatment, the microarchitecture and Tb.Pf were significantly improved in the ACLT Tgfbr2 −/− mice at 2 months after surgery relative to the ACLT WT littermates (Fig. 6a) .
Osterix-positive osteoprogenitors in the subchondral bone remained primarily on the bone surface, similarly to in ACLT WT littermates (Fig. 6b) . Moreover, co-staining of β-galactosidase (β-gal) and osteocalcin in the subchondral bone of Nestin-cre™ErøRosa26-lacZ flox/flox mice revealed that the β-gal + MSC lineage cells were located in the bone marrow in the vehicle-treated ACLT mice, whereas β-gal + cells were distributed primarily on the bone surface and were osteocalcin positive in sham-operated controls and TβRI inhibitor-treated ACLT mice (Fig. 6c) . There was less proteoglycan loss in articular cartilage in the Tgfbr2 −/− mice as compared to in the WT mice after ACLT (Fig. 6d) . Calcification of articular cartilage was also attenuated, and the thickness of the calcified cartilage remained unchanged relative to ACLT WT mice (Fig. 6d) . Immunostaining demonstrated that the expression of MMP13 and type X collagen was significantly inhibited in ACLT Tgfbr2 −/− mice relative to ACLT WT littermates, indicating inhibition of articular cartilage degeneration (Fig. 6) . The protective effects on articular cartilage in ACLT Tgfbr2 −/− mice were reflected in OARSI scores (Fig. 6e) . The disparity between the percentage of maximum contact time of the two hind limbs in WT ACLT mice did not occur in ACLT Tgfbr2 −/− littermates, as revealed by gait analysis (Fig. 6f) . Thus, these data further demonstrate that high concentrations of TGF-β initiate pathological changes in subchondral bone MSCs, contributing to the onset of osteoarthritis.
DISCUSSION
TGF-β is known for its anabolic effects on articular cartilage homeostasis by stimulating the production of extracellular matrix proteins and preventing terminal differentiation of chondrocytes 42, 43 . In this study we found that changes in mechanical loading on joints were associated with a higher number of osteoclasts in the subchondral bone as early as 7 d after surgery in the ACLT mouse model. High concentrations of TGF-β1 were activated during osteoclast bone resorption to recruit nestin-positive MSCs for the subsequent uncoupled bone formation. npg Notably, osteoclastic bone resorption was spatiotemporally uncoupled with TGF-β1-induced recruitment of nestin-positive MSCs and led to aberrant bone formation, which was further substantiated by the development of osteoarthritic-like changes in CED mice.
Relative to a single phase of uncoupled sequential bone resorption and formation in the mouse ACLT model, human osteoarthritis was more complex and had multiple phases. We found that some areas of the articular cartilage were still intact or were in the middle stage of osteoarthritis progression when analyzing specimens from subjects with late-stage osteoarthritis who underwent knee joint replacement. Consistently, the thickness of the SBP in specimens from individuals with osteoarthritis was not uniform, although the percentage distribution of the SBP was generally thicker compared to healthy subjects. Moreover, the concentrations of active TGF-β were higher in subchondral bone with articular cartilage compared to bone from healthy controls. This observation suggests that inhibition of TGF-β activity in the subchondral bone may have therapeutic effects even if individuals with osteoarthritis are not in the early stages. Our findings also reveal that TGF-β has a different role in subchondral bone as compared to its anabolic effect on articular cartilage. Thus, the location of the elevated TGF-β1 concentrations in subchondral bone triggers a cascade of events that lead to the development of osteoarthritis.
Clinical studies have reported that progression of osteoarthritis is accompanied by the accumulation of mesenchymal progenitor cells in joint tissues and synovial fluids 44, 45 . Bone marrow lesions have been identified as a prognostic factor of osteoarthritis progression, as they have been found to populate sites of cartilage destruction 16, 17, 46 . We found that elevations in TGF-β1 concentrations lead to a high number of nestin-positive MSCs in the subchondral bone marrow in various osteoarthritis rodent models. During the normal remodeling process, osteoblasts and their progenitors are located primarily at the resorption site on the bone surface. However, the altered microenvironment induced by abnormal mechanical loading may lead to in situ commitment of osteoprogenitors in bone marrow cavities. Bone marrow lesions have been characterized as less well-mineralized newly formed bone 46 . These clustered bone marrow osteoprogenitors may lead to osteoid islets in the subchondral bone marrow that are visualized as bone marrow lesions during MRI. Moreover, knockout of Tgfbr2 in nestin-positive MSCs attenuated the development of osteoarthritis in ACLT mice. This result further confirmed our hypothesis that MSCs are the target cells of aberrant TGF-β signals during osteoarthritis progression. Additionally, bone formation is often coupled with angiogenesis. It is known that the TGF-β signaling pathway in endothelial progenitor cells can promote angiogenesis 47 , and TGF-β may stimulate the paracrine machinery in MSCs that further facilitates angiogenesis 48, 49 . Our data revealed that the numbers of blood vessels were high in the subchondral bone of both ACLT and CED mice, as determined by angiography in microphil-perfused experiments. Low angiogenesis caused by inhibition of TGF-β activity may have further attenuated the de novo bone formation in the subchondral bone in the osteoarthritis joints of ACLT mice.
The subchondral bone and articular cartilage act as a functional unit in the joint 10 . In human osteoarthritis joints, the SBPs are markedly thicker relative to those of healthy subjects 50 . We modeled the subchondral bone after surgery in ACLT rodent models and found that its thickness fluctuated substantially. The capacity of chondrocytes to modulate their functional state in response to alterations in mechanical loading is relatively limited compared to in the adjacent subchondral bone. Changes in osteochondral junction are therefore probably involved in advancement of the calcified cartilage zone [51] [52] [53] . The formation of osteoid islets in the subchondral bone marrow probably precedes degeneration of articular cartilage. The results of our study suggest that careful titration of TGF-β activity inhibition may be a possible avenue for the prevention of osteoarthritis or the treatment of its early stages.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
We acquired T2-weighted images with a two-dimensional RARE (rapid acquisition with relaxation enhancement) sequence, a TE/TR (echo time/repetition time) of 15.17 ms/3,000 ms, 35 slices at thickness of 0.35 mm, field of view (FOV) of 1.75 cm × 1.75 cm and matrix size of 256 × 128. We acquired T2-weighted images with a chemical shift-selective fat saturation pulse tuned to the fat resonant frequency. All T2-weighted images were processed to a final matrix size of 256 × 256 with an isotropic resolution of 0.068 mm pixel −1 . We acquired T1-weighted images with a three-dimensional gradient echo sequence using a 30° flip angle, a TE/TR of 1.5 ms/8 ms, FOV of 1.5 cm × 1.5 cm × 1.5 cm and matrix size of 128 × 64 × 64 before and for 10 min after the injection of 0.1 ml 0.1 M gadopentetate dimeglumine. All T1-weighted images were processed to a final matrix size of 128 × 128 × 128 with an isotropic resolution of 0.12 mm pixel −1 .
mCT. We dissected knee joints from mice free of soft tissue, fixed them overnight in 70% ethanol and analyzed them by high-resolution µCT (Skyscan1172) 58 . We reconstructed and analyzed images using NRecon v1.6 and CTAn v1.9, respectively. Three-dimensional model visualization software, CTVol v2.0, was used to analyze parameters of the trabecular bone in the epiphysis. The scanner was set at a voltage of 50 kVp, a current of 200 µA and a resolution of 5.7 µm per pixel. Sagittal images of the tibiae subchondral bone were used to perform threedimensional histomorphometric analyses. We defined the region of interest to cover the whole subchondral bone medial compartment, and we used a total of five consecutive images from the medial tibial plateau for three-dimensional reconstruction and analysis. Three-dimensional structural parameters analyzed included: TV (total tissue volume; contains both trabecular and cortical bone), BV/TV (trabecular bone volume per tissue volume), Tb.Th (trabecular thickness), Tb.Sp (trabecular separation), SMI (structure model index), Conn.Dn (connectivity density) and Tb.Pf (trabecular pattern factor).
CT-based microangiography. We imaged blood vessels in bone by angiography of microphil-perfused bones 59 . Briefly, after we euthanized the animals and opened the thoracic cavity, the inferior vena cava was severed. We flushed the vascular system with 0.9% normal saline solution containing heparin sodium (100 U ml −1 ) through a needle inserted into the left ventricle. The specimens were pressure fixed with 10% neutral buffered formalin. We washed formalin from the vessels using heparinized saline solution and then injected a radiopaque silicone rubber compound containing lead chromate (Microfil MV-122, Flow Tech) to label the vasculature. Samples were stored at 4 °C overnight for contrast agent polymerization. Mouse knee joints were dissected from the specimens and soaked for 4 d in 10% neutral buffered formalin to ensure complete tissue fixation. We treated specimens for 48 h in a formic acid-based solution (Cal-Ex II) to decalcify the bone and facilitate image thresholding of the femoral vasculature from the surrounding tissues. Images were obtained using a µCT imaging system (Skyscan 1172) at a resolution of a 9 µm isotropic voxel size. A threshold of 60 was initially chosen on the basis of visual interpretation of threshold two-dimensional tomograms. Gait analysis. We performed automated gait analysis before surgery and 2, 4, 6 and 8 weeks after surgery using a CatWalk system (Noldus). All experiments were performed during the same period of the day (1 p.m. to 4 p.m.) and analyzed as previously reported 60, 61 . Briefly, we trained mice to cross the CatWalk walkway daily for 7 d before ACLT or sham operation. During the test, each mouse was placed individually in the CatWalk walkway, which consists of a glass plate (100 cm × 15 cm × 0.6 cm), plus two Plexiglas walls spaced 8 cm apart. The mouse was allowed to walk freely and traverse from one side to the other of the walkway glass plate. Two infrared light beams spaced 90 cm apart were used to detect the arrival of the mouse and control the start and end of data acquisition. We carried the recordings out when the room was completely dark, with the exception of the light from the computer screen. An LED light from an encased fluorescent lamp was emitted inside the glass plate and completely internally reflected. When the mouse paws made contact with the glass plate, light was reflected down and the illuminated contact area was recorded with a high-speed color video camera positioned underneath the glass plate connected to a computer running Catwalk software v9.1 (Noldus). Comparison was made between the ipsilateral (left) and the contralateral (right) hind paw in each run of each animal at each time point. Paired t test was used for statistical analyses.
Statistics. Data are presented as the mean ± s.d. The comparisons for OARSI scores, bone mass and microarchitecture among different groups were performed using multifactorial ANOVA. When ANOVA testing indicated overall significance of main effects without interaction between them, the difference between individual time points and sites was assessed by post hoc tests. The level of significance was set at P < 0.05. All data analyses were performed using SPSS 15.0 analysis software (SPSS Inc).
